Medicinal Cannabis Clinical Trial Shows Insomnia Symptom Improvement

  • Medicinal Cannabis Clinical Trial Shows Insomnia Symptom Improvement
  • Perth, Australia and Philadelphia-based Zelira Therapeutics Ltd, which develops of cannabis medicines has received the final report for its ZTL-101 medicinal cannabis trial for insomnia.
  • As well as the United States, Zelira will also aim to supply its insomnia formula in other markets where medicinal cannabis has been legalized including the United States, Australia, Germany, and the UK.

Read full article: sleepreviewmag.com